Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Haematology|November 21, 2008
FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantationMitsufumi Nishio, Tomoyuki Endo, Katsuya Fujimoto, et al.
European Journal of Haematology|August 23, 2006
Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphomaMitsufumi Nishio, Katsuya Fujimoto, Satoshi Yamamoto, et al.
British Journal of Haematology|April 26, 2007
Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantationMitsufumi Nishio, Katsuya Fujimoto, Satoshi Yamamoto, et al.
International Journal of Hematology|September 1, 2011
Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemiaKotaro Arita, Takeshi Kondo, Junichi Sugita, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemiaAkio Shigematsu, Takeshi Kondo, Satoshi Yamamoto, et al.
International Journal of Hematology|January 21, 2010
Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantationTakeshi Kondo, Atsushi Yasumoto, Kotaro Arita, et al.
British Journal of Haematology|April 17, 2023
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosisShota Yokoyama, Masahiro Onozawa, Shota Yoshida, et al.
Haematologica|June 13, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study GroupKoh Izumiyama, Tasuku Inao, Hideki Goto, et al.
European Journal of Haematology|July 19, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AMLToru Miyajima, Masahiro Onozawa, Shota Yoshida, et al.
International Journal of Hematology|April 22, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort studyShota Yokoyama, Masahiro Onozawa, Hiroyuki Kimura, et al.
Pageof 3